摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[1-(3,4-dimethoxyphenyl)propan-2-ylamino]-3-[4-(5-thiophen-2-yl-1H-imidazol-2-yl)phenoxy]propan-2-ol | 91944-43-3

中文名称
——
中文别名
——
英文名称
1-[1-(3,4-dimethoxyphenyl)propan-2-ylamino]-3-[4-(5-thiophen-2-yl-1H-imidazol-2-yl)phenoxy]propan-2-ol
英文别名
——
1-[1-(3,4-dimethoxyphenyl)propan-2-ylamino]-3-[4-(5-thiophen-2-yl-1H-imidazol-2-yl)phenoxy]propan-2-ol化学式
CAS
91944-43-3
化学式
C27H31N3O4S
mdl
——
分子量
493.627
InChiKey
HYHBOCVMHLENOI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    35
  • 可旋转键数:
    12
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    117
  • 氢给体数:
    3
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    参考文献:
    名称:
    .beta.1-Selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted-amino)-2-hydroxypropoxy]phenyl]imidazole class
    摘要:
    A series of 2-[4-[3-(substituted-amino)-2-hydroxypropoxy]phenyl]imidazoles is described. The compounds were investigated in vitro for beta-adrenoceptor antagonism, and several examples were found to be selective for the beta 1-adrenoceptor. The structure--activity relationship exhibited by this series of compounds is discussed. (S)-2-[p-[3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]-2-hydroxypropoxy]phenyl]-4-(2 -thienyl)imidazole [(S)-13] was over 100 times more selective than atenolol for the beta 1-adrenergic receptor and has been selected for in-depth studies.
    DOI:
    10.1021/jm00361a004
点击查看最新优质反应信息

文献信息

  • .beta.-adrenergic blocking imidazolylphenoxy propanolamines
    申请人:Merck & Co., Inc.
    公开号:US04642311A1
    公开(公告)日:1987-02-10
    Substituted imidazoles and methods for their preparation are disclosed. These imidazoles, and their salts, exhibit pharmacological activity which includes antihypertensive activity and .beta.-adrenergic blocking activity. ##STR1##
    公开了取代咪唑和其制备方法。这些咪唑及其盐表现出药理活性,包括降压活性和β-肾上腺素受体阻滞活性。
  • .beta.-blocking substituted imidazoles
    申请人:Merck & Co., Inc.
    公开号:US04853383A1
    公开(公告)日:1989-08-01
    Novel substituted imidazoles and methods for their preparation are disclosed. These imidazoles, and their salts, exhibit pharmacological activity which includes antihypertensive activity and .beta.-adrenergic blocking activity.
    揭示了一种新型替代咪唑并其制备方法。这些咪唑及其盐具有药理活性,包括抗高血压活性和β-肾上腺素能阻断活性。
  • 3-Amino-2-hydroxypropoxyaryl imidazole derivatives
    申请人:Merck & Co., Inc.
    公开号:US04440774A1
    公开(公告)日:1984-04-03
    Novel substituted imidazoles of the formula ##STR1## and methods for their preparation are disclosed. These imidazoles, and their salts, exhibit pharmacological activity which includes antihypertensive activity and .beta.-adrenergic blocking activity.
    揭示了公式为##STR1##的新型取代咪唑类化合物以及它们的制备方法。这些咪唑类化合物及其盐表现出药理活性,包括抗高血压活性和β-肾上腺素受体阻滞活性。
  • BALDWIN, JOHN J.;PONTICELLO, GERALD S.
    作者:BALDWIN, JOHN J.、PONTICELLO, GERALD S.
    DOI:——
    日期:——
  • BALDWIN, J. J.;DENNY, G. H.;HIRSCHMANN, R.;FREEDMAN, M. B.;PONTICELLO, G.+, J. MED. CHEM., 1983, 26, N 7, 950-957
    作者:BALDWIN, J. J.、DENNY, G. H.、HIRSCHMANN, R.、FREEDMAN, M. B.、PONTICELLO, G.+
    DOI:——
    日期:——
查看更多